§ 15-846. Orally administered cancer chemotherapy
West's Annotated Code of MarylandInsuranceEffective: April 8, 2014
Effective: April 8, 2014
MD Code, Insurance, § 15-846
§ 15-846. Orally administered cancer chemotherapy
(a) In this section, “cancer chemotherapy” means medication that is prescribed by a licensed physician to kill or slow the growth of cancer cells.
(b) This section applies to:
(c) An entity subject to this section may not impose dollar limits, copayments, deductibles, or coinsurance requirements on coverage for orally administered cancer chemotherapy that are less favorable to an insured or enrollee than the dollar limits, copayments, deductibles, or coinsurance requirements that apply to coverage for cancer chemotherapy that is administered intravenously or by injection.
(d) An entity subject to this section may not reclassify cancer chemotherapy or increase a copayment, deductible, coinsurance requirement, or other out-of-pocket expense imposed on cancer chemotherapy to achieve compliance with this section.
Credits
Added by Acts 2012, c. 4, § 1, eff. Oct. 1, 2012; Acts 2012, c. 5, § 1, eff. Oct. 1, 2012. Amended by Acts 2014, c. 67, § 1, eff. April 8, 2014; Acts 2014, c. 68, § 1, eff. April 8, 2014.
MD Code, Insurance, § 15-846, MD INSURANCE § 15-846
Current with all legislation from the 2023 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document |